The Proceedings of the BIRS Community
Abstract
The Chloramphenicol molecule is not stable at elevated temperatures. The eye drop preparations require cold storage and this is a challenge for low-income countries. The study assessed the stability of chloramphenicol products likely stored and transported outside the recommended refrigeration temperatures. Twenty-four Chloramphenicol eye drops were randomly sampled from local medicine stores and pharmacies in Tanzania. High-pressure-liquid chromatography was used to conduct laboratory analysis to determine the content of chloramphenicol in the products. The results indicated the sampled products contained between 69.0% to 87.0% of the active ingredient; outside the Pharmacopeia limits (90.0% - 130.0%) for Chloramphenicol ophthalmic solutions. It is likely that the products were not handled to comply with the label requirement for cold storage. Therefore, a large proportion of these eye drops in low-resource settings may not have adequate content required for the product quality.
Recommended Citation
Okezue, Mercy; Smith, Daniel T.; Musaya, Kelvin; Kihore, Nsabo; Ekeocha, Zita; Nowak, Timothy; Roth, Susan; Lee, Mikyung; Stepanovic, Michael Jr.; Maize, Holly L.; Adekoya, Adebola; Byrn, Stephen; and Clase, Kari
(2023)
"Evaluating Active Content in Chloramphenicol Ophthalmic Solutions Available in a Low-Resource Setting: A Case Study,"
The Proceedings of the BIRS Community: Vol. 1
:
Iss.
1,
Article 5.
DOI: https://doi.org/10.7771/2836-5666.1006
Available at:
https://docs.lib.purdue.edu/birstrp/vol1/iss1/5